Don't Put the Cart Before the Horse (If You want to Publish in a Journal with Impact Factor).

Arch Bronconeumol (Engl Ed)

Servicio de Neumología-Debilidad muscular y caquexia en las enfermedades respiratorias crónicas y el cáncer de pulmón, IMIM-Hospital del Mar, Barcelona, España; Departament de Ciències Experimentals i de la Salut (CEXS), Universitat Pompeu Fabra (UPF), Parc de Recerca Biomédica de Barcelona (PRBB), Barcelona, España; Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Barcelona, España.

Published: February 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arbres.2019.05.019DOI Listing

Publication Analysis

Top Keywords

cart horse
4
horse publish
4
publish journal
4
journal impact
4
impact factor
4
cart
1
publish
1
journal
1
impact
1
factor
1

Similar Publications

Retrospective cohort study on diseases and risk factors associated with death in hospitalized neonatal foals.

J Vet Intern Med

December 2024

Department of Internal Medicine, Reproduction and Population Medicine, Ghent University, Salisburylaan 133, Merelbeke 9820, Belgium.

Article Synopsis
  • The study focused on identifying diseases and risk factors leading to death in hospitalized neonatal foals.
  • Sepsis was the most common disease found, significantly increasing mortality risk, with a case fatality rate of 33.3%.
  • Key risk factors included comatose state, high L-lactate levels, and increased serum amyloid A, which could help veterinarians make informed decisions during treatment.
View Article and Find Full Text PDF

Efficacy assessment of antiretroviral drugs against equine infectious anemia virus in vitro.

Virus Res

December 2024

ANSES Animal Health Laboratory, PhEED Unit, Goustranville, France; Mixed technological Unit "Equine Health and Welfare - Organisation and Traceability of the Equine Industry" (UMT SABOT), France. Electronic address:

Equine infectious anemia virus (EIAV) is an equine lentivirus related to human immunodeficiency virus type 1 (HIV-1). Both viruses are related among the Retroviridae family, but their clinical manifestations are different as EIAV causes a long persistent infection with no progressive immune dysfunction in most cases. Today, no treatment is approved against EIAV, contrary to HIV-1, manageable through antiretroviral therapy, known as HAART (highly active antiretroviral therapy) or cART (combination antiretroviral therapy).

View Article and Find Full Text PDF

Working equids support the livelihoods of millions of low-income households worldwide and face several welfare challenges. Although equipment-related wounds are common, little is known about specific risk factors. This cross-sectional study surveyed equids used for cart-work in three Ethiopian towns.

View Article and Find Full Text PDF

Cannabis and Pain Management.

J Am Board Fam Med

October 2024

From the Family Medicine and Addiction Medicine, SSM Health SLUCare and Saint Louis University School of Medicine (FR); Family Medicine and Addiction Medicine, SSM Health SLUCare and Saint Louis University School of Medicine (SL); Saint Louis University School of Medicine (JH); Anesthesiology and Critical Care, SSM Health SLUCare and Saint Louis University School of Medicine (GP); Family Medicine and Addiction Medicine, SSM Health SLUCare and Saint Louis University School of Medicine (AH).

Family physicians are fielding questions about cannabis --particularly for the use of cannabis for treatment of pain. Like about every substance ingested to treat medical conditions, cannabis has risks and benefits. But regarding evidence-based practice and practice-based recommendations for patients about cannabis use, the cart is in front of the horse.

View Article and Find Full Text PDF

The impact of aging on HIV-1-related neurocognitive impairment.

Ageing Res Rev

December 2024

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address:

Article Synopsis
  • HIV-1-related neurocognitive impairment affects up to 50% of people living with HIV, even with effective antiretroviral therapy (cART), complicating treatment and understanding of its causes.
  • Biological aging is identified as a possible factor in the development and progression of this impairment, especially as life expectancy for individuals on cART approaches that of those without HIV.
  • The text aims to explore how aging and HIV-1 infection interact at the clinical and molecular levels, highlighting the need for a clearer understanding of these combined effects on neurocognitive health.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!